nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobunolol—ADRB2—polycystic ovary syndrome	0.847	1	CbGaD
Levobunolol—Timolol—ADRB3—polycystic ovary syndrome	0.00209	0.18	CrCbGaD
Levobunolol—Nadolol—ADRB3—polycystic ovary syndrome	0.00166	0.143	CrCbGaD
Levobunolol—Bupranolol—ADRB3—polycystic ovary syndrome	0.00158	0.137	CrCbGaD
Levobunolol—Pindolol—ADRB3—polycystic ovary syndrome	0.00104	0.09	CrCbGaD
Levobunolol—Timolol—ADRB2—polycystic ovary syndrome	0.000794	0.0685	CrCbGaD
Levobunolol—Carteolol—ADRB2—polycystic ovary syndrome	0.000708	0.0611	CrCbGaD
Levobunolol—Nadolol—ADRB2—polycystic ovary syndrome	0.000631	0.0544	CrCbGaD
Levobunolol—Bupranolol—ADRB2—polycystic ovary syndrome	0.000602	0.0519	CrCbGaD
Levobunolol—Propranolol—ADRB3—polycystic ovary syndrome	0.000569	0.0491	CrCbGaD
Levobunolol—Salbutamol—ADRB2—polycystic ovary syndrome	0.000566	0.0488	CrCbGaD
Levobunolol—Penbutolol—ADRB2—polycystic ovary syndrome	0.000551	0.0475	CrCbGaD
Levobunolol—Pindolol—ADRB2—polycystic ovary syndrome	0.000397	0.0342	CrCbGaD
Levobunolol—ADRB2—GPCR ligand binding—NPB—polycystic ovary syndrome	0.000374	0.00263	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA1D—polycystic ovary syndrome	0.000372	0.00262	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA1B—polycystic ovary syndrome	0.00037	0.00261	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA1B—polycystic ovary syndrome	0.000362	0.00255	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—FSHR—polycystic ovary syndrome	0.000358	0.00252	CbGpPWpGaD
Levobunolol—ADRB1—Calcium Regulation in the Cardiac Cell—CAMK2D—polycystic ovary syndrome	0.000352	0.00248	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—FSHR—polycystic ovary syndrome	0.00035	0.00247	CbGpPWpGaD
Levobunolol—ADRB2—Calcium Regulation in the Cardiac Cell—CAMK2D—polycystic ovary syndrome	0.000344	0.00243	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRA1A—polycystic ovary syndrome	0.000327	0.00231	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA1A—polycystic ovary syndrome	0.00032	0.00226	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.000319	0.00225	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.000319	0.00225	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.000315	0.00222	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.000312	0.0022	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.000312	0.0022	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.000308	0.00217	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.000306	0.00216	CbGpPWpGaD
Levobunolol—ADRB1—G alpha (s) signalling events—ADRB2—polycystic ovary syndrome	0.000306	0.00215	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.0003	0.00211	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.000298	0.0021	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.000292	0.00206	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.000289	0.00204	CbGpPWpGaD
Levobunolol—ADRB1—G alpha (s) signalling events—GNAS—polycystic ovary syndrome	0.000283	0.002	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.000283	0.002	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.000282	0.00199	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.00028	0.00198	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.000278	0.00196	CbGpPWpGaD
Levobunolol—ADRB2—G alpha (s) signalling events—GNAS—polycystic ovary syndrome	0.000277	0.00195	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.000275	0.00194	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.000274	0.00193	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.000272	0.00192	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.00027	0.0019	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.000267	0.00188	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.000264	0.00186	CbGpPWpGaD
Levobunolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—polycystic ovary syndrome	0.000264	0.00186	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.000261	0.00184	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.000261	0.00184	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.000255	0.0018	CbGpPWpGaD
Levobunolol—ADRB1—Calcium Regulation in the Cardiac Cell—GNAS—polycystic ovary syndrome	0.000245	0.00172	CbGpPWpGaD
Levobunolol—ADRB2—Calcium Regulation in the Cardiac Cell—GNAS—polycystic ovary syndrome	0.000239	0.00169	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.000238	0.00168	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.000233	0.00165	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.000233	0.00164	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.000228	0.00161	CbGpPWpGaD
Levobunolol—Propranolol—ADRB2—polycystic ovary syndrome	0.000217	0.0187	CrCbGaD
Levobunolol—ADRB1—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.000216	0.00152	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.000213	0.0015	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.000211	0.00149	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.000209	0.00147	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.000205	0.00145	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—LHB—polycystic ovary syndrome	0.000203	0.00143	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.000201	0.00142	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—LHB—polycystic ovary syndrome	0.000199	0.0014	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.000198	0.0014	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—NPB—polycystic ovary syndrome	0.000196	0.00138	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.000195	0.00138	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.000194	0.00137	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—NPB—polycystic ovary syndrome	0.000192	0.00135	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000191	0.00135	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000191	0.00135	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.000191	0.00135	CbGpPWpGaD
Levobunolol—ADRB1—G alpha (s) signalling events—POMC—polycystic ovary syndrome	0.000191	0.00135	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00019	0.00134	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000187	0.00132	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000187	0.00132	CbGpPWpGaD
Levobunolol—ADRB2—G alpha (s) signalling events—POMC—polycystic ovary syndrome	0.000187	0.00132	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—SCT—polycystic ovary syndrome	0.000186	0.00131	CbGpPWpGaD
Levobunolol—Propranolol—CYP1A1—polycystic ovary syndrome	0.000186	0.016	CrCbGaD
Levobunolol—ADRB1—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.000181	0.00128	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00018	0.00127	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00018	0.00127	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.000178	0.00125	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000177	0.00125	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.000176	0.00124	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.000176	0.00124	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000176	0.00124	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000173	0.00122	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000172	0.00121	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.00017	0.0012	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000169	0.00119	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000165	0.00116	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.000164	0.00115	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000164	0.00115	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.000164	0.00115	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00016	0.00113	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00016	0.00113	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00016	0.00113	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000159	0.00112	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000156	0.0011	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.000153	0.00108	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00015	0.00106	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000149	0.00105	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.000146	0.00103	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000145	0.00102	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000145	0.00102	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000145	0.00102	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000142	0.000999	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000141	0.000997	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000134	0.000945	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000132	0.000934	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000132	0.00093	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000131	0.000927	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000131	0.000924	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00013	0.000914	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000129	0.000909	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000129	0.000907	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000121	0.00085	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00012	0.000844	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000118	0.000832	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000117	0.000826	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000116	0.000819	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NPB—polycystic ovary syndrome	0.000116	0.000816	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000115	0.000809	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000114	0.000801	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NPB—polycystic ovary syndrome	0.000113	0.000799	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000112	0.000791	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000112	0.000791	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000111	0.000782	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00011	0.000773	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00011	0.000772	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000107	0.000758	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000107	0.000755	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000105	0.000743	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000105	0.000741	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000105	0.000738	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000104	0.000735	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000103	0.000727	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000103	0.000725	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000103	0.000723	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000102	0.000722	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000102	0.000719	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000102	0.000718	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000101	0.000709	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.0001	0.000707	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	9.96e-05	0.000702	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—SCT—polycystic ovary syndrome	9.76e-05	0.000688	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—LHCGR—polycystic ovary syndrome	9.66e-05	0.000681	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PTGER3—polycystic ovary syndrome	9.66e-05	0.000681	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—SCT—polycystic ovary syndrome	9.55e-05	0.000673	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PTGER3—polycystic ovary syndrome	9.45e-05	0.000667	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—LHCGR—polycystic ovary syndrome	9.45e-05	0.000667	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	9.31e-05	0.000657	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	9.11e-05	0.000642	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	9.1e-05	0.000641	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PTAFR—polycystic ovary syndrome	9.04e-05	0.000637	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	8.9e-05	0.000627	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PTAFR—polycystic ovary syndrome	8.84e-05	0.000623	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	8.78e-05	0.000619	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	8.58e-05	0.000605	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	8.54e-05	0.000602	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	8.35e-05	0.000589	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—INHBB—polycystic ovary syndrome	8.32e-05	0.000587	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—INHBB—polycystic ovary syndrome	8.14e-05	0.000574	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PDE3B—polycystic ovary syndrome	7.77e-05	0.000548	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PDE3B—polycystic ovary syndrome	7.6e-05	0.000536	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	7.57e-05	0.000534	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	7.41e-05	0.000522	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—FSHR—polycystic ovary syndrome	7.07e-05	0.000499	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—POMC—polycystic ovary syndrome	6.93e-05	0.000488	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—FSHR—polycystic ovary syndrome	6.92e-05	0.000488	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—GHRL—polycystic ovary syndrome	6.88e-05	0.000485	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—POMC—polycystic ovary syndrome	6.78e-05	0.000478	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—GHRL—polycystic ovary syndrome	6.73e-05	0.000474	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	6.65e-05	0.000469	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	6.51e-05	0.000459	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	6.47e-05	0.000456	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	6.33e-05	0.000446	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—FST—polycystic ovary syndrome	6.3e-05	0.000445	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	6.27e-05	0.000442	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ADRB3—polycystic ovary syndrome	6.23e-05	0.000439	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—FST—polycystic ovary syndrome	6.17e-05	0.000435	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—LHB—polycystic ovary syndrome	6.15e-05	0.000434	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ADRB3—polycystic ovary syndrome	6.09e-05	0.00043	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—LHB—polycystic ovary syndrome	6.02e-05	0.000424	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GNRH1—polycystic ovary syndrome	6.01e-05	0.000424	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GNRH1—polycystic ovary syndrome	5.88e-05	0.000415	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	5.83e-05	0.000411	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	5.81e-05	0.00041	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—SCT—polycystic ovary syndrome	5.77e-05	0.000407	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	5.7e-05	0.000402	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	5.69e-05	0.000401	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	5.69e-05	0.000401	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—SCT—polycystic ovary syndrome	5.64e-05	0.000398	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	5.5e-05	0.000388	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—FGF18—polycystic ovary syndrome	5.41e-05	0.000381	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	5.38e-05	0.000379	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—RBP4—polycystic ovary syndrome	5.36e-05	0.000378	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—FGF18—polycystic ovary syndrome	5.29e-05	0.000373	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—GNAS—polycystic ovary syndrome	5.28e-05	0.000372	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—RBP4—polycystic ovary syndrome	5.24e-05	0.00037	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—GNAS—polycystic ovary syndrome	5.16e-05	0.000364	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—YAP1—polycystic ovary syndrome	5e-05	0.000353	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GAB1—polycystic ovary syndrome	4.94e-05	0.000348	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—YAP1—polycystic ovary syndrome	4.9e-05	0.000345	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GAB1—polycystic ovary syndrome	4.83e-05	0.00034	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—INSR—polycystic ovary syndrome	4.72e-05	0.000333	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—INSR—polycystic ovary syndrome	4.62e-05	0.000326	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	4.48e-05	0.000316	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	4.41e-05	0.000311	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	4.39e-05	0.000309	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PGR—polycystic ovary syndrome	4.37e-05	0.000308	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	4.32e-05	0.000304	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PGR—polycystic ovary syndrome	4.28e-05	0.000301	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GHRL—polycystic ovary syndrome	4.06e-05	0.000286	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PLAT—polycystic ovary syndrome	4.06e-05	0.000286	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GHRL—polycystic ovary syndrome	3.97e-05	0.00028	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PLAT—polycystic ovary syndrome	3.97e-05	0.00028	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—POMC—polycystic ovary syndrome	3.91e-05	0.000276	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ATF1—polycystic ovary syndrome	3.88e-05	0.000273	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—POMC—polycystic ovary syndrome	3.83e-05	0.00027	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—ATF1—polycystic ovary syndrome	3.79e-05	0.000267	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	3.78e-05	0.000267	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	3.76e-05	0.000265	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	3.7e-05	0.000261	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	3.68e-05	0.000259	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NGFR—polycystic ovary syndrome	3.58e-05	0.000252	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—POMC—polycystic ovary syndrome	3.55e-05	0.000251	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PRL—polycystic ovary syndrome	3.54e-05	0.00025	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NGFR—polycystic ovary syndrome	3.5e-05	0.000247	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—POMC—polycystic ovary syndrome	3.48e-05	0.000245	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PRL—polycystic ovary syndrome	3.47e-05	0.000245	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—AKT2—polycystic ovary syndrome	3.42e-05	0.000241	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—ADRB2—polycystic ovary syndrome	3.36e-05	0.000237	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—AKT2—polycystic ovary syndrome	3.34e-05	0.000236	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GNAS—polycystic ovary syndrome	3.12e-05	0.00022	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GNAS—polycystic ovary syndrome	3.05e-05	0.000215	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.97e-05	0.000209	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NRG1—polycystic ovary syndrome	2.92e-05	0.000206	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.91e-05	0.000205	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NRG1—polycystic ovary syndrome	2.85e-05	0.000201	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IRS2—polycystic ovary syndrome	2.5e-05	0.000176	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—LEP—polycystic ovary syndrome	2.44e-05	0.000172	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IRS2—polycystic ovary syndrome	2.44e-05	0.000172	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—LEP—polycystic ovary syndrome	2.39e-05	0.000169	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IRS1—polycystic ovary syndrome	2.18e-05	0.000154	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IRS1—polycystic ovary syndrome	2.13e-05	0.00015	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—POMC—polycystic ovary syndrome	2.1e-05	0.000148	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—INS—polycystic ovary syndrome	2.09e-05	0.000147	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—POMC—polycystic ovary syndrome	2.05e-05	0.000145	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—INS—polycystic ovary syndrome	2.04e-05	0.000144	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IGF1—polycystic ovary syndrome	2.02e-05	0.000142	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—AKT2—polycystic ovary syndrome	2.02e-05	0.000142	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IGF1—polycystic ovary syndrome	1.98e-05	0.000139	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—AKT2—polycystic ovary syndrome	1.97e-05	0.000139	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.92e-05	0.000135	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.88e-05	0.000132	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—IL6—polycystic ovary syndrome	1.54e-05	0.000109	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—IL6—polycystic ovary syndrome	1.51e-05	0.000107	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.32e-05	9.3e-05	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.29e-05	9.1e-05	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IL6—polycystic ovary syndrome	9.12e-06	6.43e-05	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IL6—polycystic ovary syndrome	8.93e-06	6.29e-05	CbGpPWpGaD
